✦ LIBER ✦

Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications

✍ Scribed by Andrew Krentz

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 438 KB
Volume: 25
Category: Article
ISSN: 1520-7552
DOI: 10.1002/dmrr.937

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of multiple complications in

Development of multiple complications in type 2 diabetes is associated with the increase of multiple markers of chronic inflammation

✍ Jawl-Shan Hwang; Tsu-Lan Wu; S.C. Chou; C. Ho; Pi-Yueh Chang; Kuo-Chien Tsao; Je 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

## Abstract Patients with type 2 diabetes (T2DM) are known at risk for developing cardiovascular disease (CVD), nephropathy, and cancer. We were interested to find out whether multiple markers associated with chronic inflammation are detectable in patients with T2DM and are increased in patients wi

Effects of insulin and oral anti-diabeti

Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects

✍ J. Joya-Galeana; M. Fernandez; A. Cervera; S. Reyna; S. Ghosh; C. Triplitt; N. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

Effects of the α-glucosidase inhibitor a

Effects of the α-glucosidase inhibitor acarbose on the development of long-term complications in diabetic animals: pathophysiological and therapeutic implications

✍ Werner Creutzfeldt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

Short-term studies with acarbose have demonstrated its ef®cacy in reducing postprandial blood glucose levels and glycated haemoglobin (HbA 1c ) levels. These effects would be expected to translate into improvements in long-term complications of diabetes, but such data are not yet available due to th

Programmed disorders of β-cell developme

Programmed disorders of β-cell development and function as one cause for type 2 diabetes? The GK rat paradigm

✍ Bernard Portha 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Now that the reduction in β-mass has been clearly established in humans with type 2 diabetes mellitus (T2DM) [1][2][3][4], the debate focuses on the possible mechanisms responsible for decreased β-cell number and impaired β-cell function and their multifactorial etiology. Appropriate inbred rodent m

Effects of finasteride, a type 2 5-alpha

Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)

✍ Prahalada, S.; Tarantal, A. F.; Harris, G. S.; Ellsworth, K. P.; Clarke, A. P.; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 3 views

In genetic male fetuses, dihydrotestosterone (DHT) plays an important role in normal prostatic and external genital differentiation. The enzyme steroid 5-alpha reductase (5 alpha R) catalyzes the conversion of testosterone (T) to DHT. The importance of 5 alpha R in sexual differentiation is evident

Effects of long-term treatment with α-gl

Effects of long-term treatment with α-glucosidase inhibitor on the peripheral nerve function and structure in Goto-Kakizaki rats: a genetic model for Type 2 diabetes

✍ Ryuichi Wada; Motoi Koyama; Hiroki Mizukami; Hiroyuki Odaka; Hitoshi Ikeda; Soro 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

Background Continuous hyperglycemia is implicated in the pathogenesis of chronic diabetic complications. It is not well known, however, how and to what extent the development of neuropathy is inhibited by blood glucose control in subjects with Type 2 diabetes. We investigated therefore the effects o